What is the evidence level for Nafarelin?

Nafarelin is rated Level A. Its current research status is FDA Approved.

What is Nafarelin best known for?

Endometriosis treatment, central precocious puberty, intranasal GnRH agonist research

Where can I read the full Nafarelin evidence review?

The full evidence review is available at https://examinepeptides.com/library/nafarelin.

Sexual Health / legal status / Last reviewed 2026-06-02

Nafarelin Legal Status: Approval, Research Use, and Regulatory Notes

FDA-approved prescription medication (Synarel). Prescription only. Not a controlled substance.

Read the full Nafarelin guide Browse answer pages

Direct Answer

Nafarelin (Synarel) is FDA-approved for endometriosis and central precocious puberty via intranasal delivery - an unusual route for a peptide drug that demonstrates its unique pharmaceutical development. Phase 3 evidence for both indications is solid. For GnRH agonist research requiring intranasal administration, nafarelin is the validated option.

Evidence grade: Level A
Research status: FDA Approved
Category: Sexual Health
Best for: Endometriosis treatment, central precocious puberty, intranasal GnRH agonist research

Legal and Regulatory Status

FDA-approved prescription medication (Synarel). Prescription only. Not a controlled substance.

Approval Stage

Nafarelin is listed as FDA Approved. Approved uses, if any, are indication-specific and do not automatically apply to other claims.

Compliance Notes

Nasal congestion or use of nasal decongestant sprays may reduce absorption
Bone density monitoring recommended for treatment >6 months
Not for use in pregnancy (Category X)
Add-back hormonal therapy recommended for endometriosis treatment beyond 6 months

Evidence Page

For the complete evidence review, see the main Nafarelin guide linked below.

Evidence Snapshot

Evidence grade	Level A
Research status	FDA Approved
Best supported outcomes	Endometriosis Pain Relief (Level A), Central Precocious Puberty Treatment (Level A), and Uterine Fibroid Reduction (Level B)
Primary citation count	3
Last reviewed	2026-06-02

Related Guides

How to Cite This Page

ExaminePeptides. "Nafarelin Legal Status: Approval, Research Use, and Regulatory Notes." Last reviewed 2026-06-02. https://examinepeptides.com/answers/nafarelin-legal-status/

This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.